Rubiadin Regulates Bone Metabolism in Ovariectomized Rat Model by Inhibition of osteoclast formation and differentiation

[1]  L. Qin,et al.  Metabolomics profiling provides valuable insights into the underlying mechanisms of Morinda officinalis on protecting glucocorticoid‐induced osteoporosis , 2019, Journal of pharmaceutical and biomedical analysis.

[2]  T. Han,et al.  Rubiadin-1-methyl ether from Morinda officinalis How. Inhibits osteoclastogenesis through blocking RANKL-induced NF-κB pathway. , 2018, Biochemical and biophysical research communications.

[3]  Xinying Ji,et al.  The triptolide‐induced apoptosis of osteoclast precursor by degradation of cIAP2 and treatment of rheumatoid arthritis of TNF‐transgenic mice , 2018, Phytotherapy research : PTR.

[4]  M. Rasool,et al.  Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF‐&kgr;B signalling pathway , 2018, Life sciences.

[5]  Yung-Hyun Choi,et al.  Sargassum serratifolium attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and activation of the Nrf2/HO-1 signaling pathway. , 2018, Bioscience trends.

[6]  Yu-Ching Lin,et al.  Risk factors and quality of life for the occurrence of hip fracture in postmenopausal women , 2018, Biomedical journal.

[7]  Chengqi He,et al.  Review Effectsof PulsedElectromagnetic Fieldson PostmenopausalOsteoporosis , 2017 .

[8]  L. Kiesel,et al.  Role of the RANK/RANKL pathway in breast cancer. , 2016, Maturitas.

[9]  A. Oryan,et al.  Three-Dimensional Porous Gelapin–Simvastatin Scaffolds Promoted Bone Defect Healing in Rabbits , 2015, Calcified Tissue International.

[10]  T. Jukić,et al.  Digital orthopantomograms in osteoporosis detection: mandibular density and mandibular radiographic indices as skeletal BMD predictors. , 2014, Dento maxillo facial radiology.

[11]  I. Kwon,et al.  Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species , 2011, Experimental & Molecular Medicine.

[12]  T. Han,et al.  Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. , 2011, Chemico-biological interactions.

[13]  Xu Feng,et al.  Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis , 2010, Expert opinion on therapeutic targets.

[14]  F. Otsuka,et al.  Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling , 2010, Regulatory Peptides.

[15]  J. Eisman,et al.  Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  J. Pelletier,et al.  Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. , 2009, Rheumatology.

[17]  C. Zheng,et al.  Antiosteoporotic Activity of Anthraquinones from Morinda officinalis on Osteoblasts and Osteoclasts , 2009, Molecules.

[18]  Ting Han,et al.  Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. , 2008, Journal of ethnopharmacology.

[19]  M. Heymann,et al.  OPG, RANK and RANK ligand expression in thyroid lesions , 2008, Regulatory Peptides.

[20]  M. Padrines,et al.  Key roles of the OPG–RANK–RANKL system in bone oncology , 2007, Expert review of anticancer therapy.

[21]  L. Notarangelo,et al.  Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis , 2000, Nature Genetics.

[22]  S. Dixon,et al.  Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. , 2008, Bone.